Back
Adaptive Biotechnologies Quote, Financials, Valuation and Earnings
Sponsored
ADPT
Sponsored
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Buy
67
ADPT
Adaptive Biotechnologies
Last Price:
3.11
Seasonality Move:
7.56%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.Adaptive Biotechnologies Price Quote
$3.11
-0.11 (-3.42%)
(Updated: May 7, 2024 at 6:55 PM ET)
Adaptive Biotechnologies Key Stats
Buy
67
Adaptive Biotechnologies (ADPT)
is a Buy
Day range:
$3.01 - $3.23
52-week range:
$2.28 - $9.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.73
P/B ratio:
1.51%
Volume:
1.5M
Avg. volume:
2M
1-year change:
-49.29%
Market cap:
$467.2M
Revenue:
$170.3M
EPS:
$-1.56
How Much Does Adaptive Biotechnologies Make?
-
How Much Are Adaptive Biotechnologies's Sales Annually?
ADPT Revenues are $170.3M -
How Much Profit Does Adaptive Biotechnologies's Make A Year?
ADPT net income is -$225.3M
Is Adaptive Biotechnologies Growing As A Company?
-
What Is Adaptive Biotechnologies's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.17% -
What Is Adaptive Biotechnologies's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Adaptive Biotechnologies Stock Price Performance
-
Did Adaptive Biotechnologies Stock Go Up Last Month?
Adaptive Biotechnologies share price went up by 24.81% last month -
Did ADPT's Share Price Rise Over The Last Year?
ADPT share price fell by -49.29% over the past 1 year
What Is Adaptive Biotechnologies 52-Week High & Low?
-
What Is Adaptive Biotechnologies’s 52-Week High Share Price?
Adaptive Biotechnologies has traded as high as $9.08 over the past 52 weeks -
What Is Adaptive Biotechnologies’s 52-Week Low Share Price?
Adaptive Biotechnologies has traded as low as $2.28 over the past 52 weeks
Adaptive Biotechnologies Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Adaptive Biotechnologies?
-
How Much Debt Does Adaptive Biotechnologies Have?
Total long term debt quarterly is $0 -
How Much Cash Does Adaptive Biotechnologies Have?
Cash and short term investments quarterly total is $346.4M -
What Is Adaptive Biotechnologies’s Book Value Per Share?
Book value per share is 2.13
Is Adaptive Biotechnologies Cash Flow Positive?
-
What Is ADPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$156.3M -
What Is Adaptive Biotechnologies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $2.2M -
What Is Adaptive Biotechnologies’s Cash Flow From Investing?
Cash flow from investing (TTM) is $129.6M
Adaptive Biotechnologies Return On Invested Capital
-
Is Management Doing A Good Job?
ADPT return on invested capital is -57.64% -
What Is Adaptive Biotechnologies Return On Assets?
ROA measures how assets are converting to revenues and is -29.71% -
What Is ADPT Return On Equity?
ROE is a measure of profitability and is -57.64%
Adaptive Biotechnologies Earnings Date & Stock Price
-
What Is Adaptive Biotechnologies's Stock Price Today?
A single share of ADPT can be purchased today for 3.22 -
What Is Adaptive Biotechnologies’s Stock Symbol?
Adaptive Biotechnologies trades on the nasdaq under the ticker symbol: ADPT -
When Is Adaptive Biotechnologies’s Next Earnings Date?
The next quarterly earnings date for Adaptive Biotechnologies is scheduled on May 7, 2024 -
When Is ADPT's next ex-dividend date?
Adaptive Biotechnologies's next ex-dividend date is June 4, 2020 -
How To Buy Adaptive Biotechnologies Stock?
You can buy Adaptive Biotechnologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Adaptive Biotechnologies Competitors
-
Who Are Adaptive Biotechnologies's Competitors?
Below is a list of companies who compete with Adaptive Biotechnologies or are related in some way:
Adaptive Biotechnologies Dividend Yield
Data Unavailable
Adaptive Biotechnologies Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 6.99% |
Revenue: | -17.06% | -5.53% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 6.67 |
Upside from Last Price: | 107.04% |